Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Liability Protections For Pandemic Vaccine Makers Provided In Spending Law

Executive Summary

The 2006 defense appropriations law includes liability protections for manufacturers of pandemic countermeasures but not more extensive patent incentives that had been proposed in some bills focused on bioterror products
Advertisement

Related Content

FDA Makes Preemption Case Once And For All In Final Labeling Rule
FDA Makes Preemption Case Once And For All In Final Labeling Rule
Avian Flu Plan From Administration Places Vaccines First, Antivirals Second
Hatch/Lieberman “BioShield II” Sets 180-Day Window For “Wild Card” Patents
Hatch/Lieberman “BioShield II” Sets 180-Day Window For “Wild Card” Patents
Advertisement
UsernamePublicRestriction

Register

PS046706

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel